Sinovac Biotech Co., Ltd.
Clinical trials sponsored by Sinovac Biotech Co., Ltd., explained in plain language.
Vaccine developer and manufacturer, known for COVID-19 vaccine CoronaVac.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Polio vaccine showdown: which sequence protects best? Results expected Sep 2026 (estimated)
- Rabies vaccine batch check: will it pass the test? Results expected Sep 2026 (estimated) 🚀 Make-or-break
- New meningitis vaccine for kids shows promise in large trial Results expected Nov 2026 (estimated) 🚀 Make-or-break
- New meningitis vaccine for toddlers shows promise in major trial Results expected Jan 2027 (estimated) 🚀 Make-or-break
- Can a vaccine shield children from severe hand, foot, and mouth disease? Results expected Jan 2027 (estimated)
-
Can a stronger flu shot better protect seniors?
Vaccine CompletedThis trial is testing whether a high-dose flu vaccine is safe and triggers a stronger immune response in adults aged 60 and older compared to the standard-dose vaccine. Participants receive a single injection and are monitored for side effects and antibody levels. The goal is to …
Phase 1 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Vaccine
Last updated Aug 01, 2026 00:00 UTC
-
New vaccine aims to tackle two viruses behind hand, foot, and mouth disease
Vaccine CompletedThis clinical trial tested a new vaccine designed to protect against two viruses (EV71 and CA16) that cause hand, foot, and mouth disease and herpangina. The study involved 744 healthy adults and children, including kids as young as 6 months. Researchers checked the vaccine's saf…
Phase 1/2 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Vaccine
Last updated Jun 28, 2026 00:00 UTC
-
New vaccine aims to shield kids from hand, foot, and mouth disease
Vaccine CompletedThis study tested a new vaccine designed to protect against hand, foot, and mouth disease and herpangina, which are common viral infections in children. The trial involved 552 healthy adults and children aged 6 months to 12 years. Participants received either a low, medium, or hi…
Phase 1/2 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Vaccine
Last updated Jun 27, 2026 09:10 UTC
-
New rabies vaccine schedule tested in 2,000 volunteers
Vaccine CompletedThis study tested a new rabies vaccine given in different schedules after exposure. It involved 2,040 healthy people aged 10-60. The goal was to see if the vaccine triggers a strong immune response and is safe compared to a standard vaccine.
Phase 3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Vaccine
Last updated Jun 27, 2026 08:12 UTC
-
Can toddlers get three vaccines at once? new study says yes
Vaccine CompletedThis study tested whether giving a booster polio vaccine (sIPV) at the same time as MMR and hepatitis A vaccines is safe and works well in toddlers. About 889 healthy children aged 18 to 22 months who had already received their first polio and MMR shots took part. Researchers che…
Phase 4 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Vaccine
Last updated Jun 27, 2026 08:11 UTC
-
Polio vaccine works alongside routine infant shots, study finds
Prevention CompletedThis study tested whether a polio vaccine (sIPV) is still effective when given at the same time as other routine vaccines for infants, like those for pneumonia, diphtheria, tetanus, and whooping cough. About 1,400 babies in Bangladesh and Pakistan received the polio vaccine eithe…
Phase 3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: Prevention
Last updated Jun 27, 2026 08:05 UTC